{"name":"Mayne Pharma International Pty Ltd","slug":"mayne-pharma-international-pty-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":5,"colorKey":"immunology","drugs":[{"name":"Permethrin Cream, 5%","genericName":"Permethrin Cream, 5%","slug":"permethrin-cream-5","indication":"Scabies (Sarcoptes scabiei infestation)","status":"marketed"},{"name":"Elimite","genericName":"Elimite","slug":"elimite","indication":"Other","status":"marketed"},{"name":"Lozanoc","genericName":"Lozanoc","slug":"lozanoc","indication":"Other","status":"marketed"},{"name":"Placebo 0% Lotion","genericName":"Placebo 0% Lotion","slug":"placebo-0-lotion","indication":"Other","status":"phase_3"},{"name":"Sporanox","genericName":"Sporanox","slug":"sporanox","indication":"Other","status":"marketed"}]},{"name":"Immunology","slug":"immunology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Halobetasol Topical Foam","genericName":"Halobetasol Topical Foam","slug":"halobetasol-topical-foam","indication":"Inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses","status":"marketed"}]}],"pipeline":[{"name":"Halobetasol Topical Foam","genericName":"Halobetasol Topical Foam","slug":"halobetasol-topical-foam","phase":"marketed","mechanism":"Halobetasol propionate is a potent corticosteroid that suppresses inflammatory and immune responses in the skin by binding to glucocorticoid receptors.","indications":["Inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses","Psoriasis","Eczema","Lichen planus","Other corticosteroid-responsive skin conditions"],"catalyst":""},{"name":"Permethrin Cream, 5%","genericName":"Permethrin Cream, 5%","slug":"permethrin-cream-5","phase":"marketed","mechanism":"Permethrin is a synthetic pyrethroid insecticide that disrupts sodium channel function in the nervous system of parasitic arthropods, causing paralysis and death.","indications":["Scabies (Sarcoptes scabiei infestation)","Head lice (Pediculus humanus capitis)","Body lice (Pediculus humanus humanus)","Pubic lice (Phthirus pubis)"],"catalyst":""},{"name":"Elimite","genericName":"Elimite","slug":"elimite","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Lozanoc","genericName":"Lozanoc","slug":"lozanoc","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Placebo 0% Lotion","genericName":"Placebo 0% Lotion","slug":"placebo-0-lotion","phase":"phase_3","mechanism":"Placebo 0% Lotion contains no active pharmaceutical ingredient and produces therapeutic effects solely through placebo response mechanisms.","indications":[],"catalyst":""},{"name":"Sporanox","genericName":"Sporanox","slug":"sporanox","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxOVEk5NFMxTk8tWGhlT0tBTHg5cnhGLUVYeF9TZEY2M0kyMDg0SXBJemdQME1TTDhpeldsT2tCclFoejJ1Y2hEWnFiZnBfaWJCMVVFQmV2NkdxcmY0X1FSY3VUbFlGWlNDY3Boakkza0NhVm1TTWxjdTZDNjExemF0N3ZZZHhxdXB4dnVQeHlkcnp0YjJCODl6MS1ZOTl1anJyVzcwOENCQWY?oc=5","date":"2026-04-07","type":"pipeline","source":"kalkinemedia.com","summary":"ASX 20: What US tariffs mean for CSL and Mayne Pharma shares - kalkinemedia.com","headline":"ASX 20: What US tariffs mean for CSL and Mayne Pharma shares","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxQODZZcFEzZGtQaTBIMDZoQ2lCN1pHZTVCTmQ2ZHRwVEhpclFJc1NwXy1YUVRZMWZfRC1DekVuZk5fdGQ1QkJsQlI2NmtDX2J0Y3VDYll2clFIY3ZGVGN5aFdCZ3I0dmdkSUVJY2JRckJURHh5VE9oM21XcEN5aEhMcVJrcDk2aFJ3SDlOUnJZSjhDY1Q3czE3dnJaYkFGZ1gxTEIxVDFsemF5SFRxdmw3YlJ4RUhYUQ?oc=5","date":"2026-03-31","type":"pipeline","source":"TipRanks","summary":"Citigroup Group Ceases to Be Substantial Holder in Mayne Pharma - TipRanks","headline":"Citigroup Group Ceases to Be Substantial Holder in Mayne Pharma","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-02-24","type":"earnings","source":"simplywall.st","summary":"Mayne Pharma Group H1 2026 Loss Narrowing Tests Bearish Narratives On Profitability Path - simplywall.st","headline":"Mayne Pharma Group H1 2026 Loss Narrowing Tests Bearish Narratives On Profitability Path","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxNSkRyeHZPb1ZQZzE4UW5DQmR2cXBMc2RiSFZMRW01ODh1MEpzTlpKNWNKbGFmbUF6dGF2eEdQaVBRem5CSFl4MmJvOUhlWV9BWVFxY0VmT3RLTlZRVk5RbE90TU13YzJwd0ZrRTRDM1dtekZwVkwtYjVNTzY0dENqemhmamlPSy1jaGtsYmdlSFZEUnVj?oc=5","date":"2026-02-17","type":"pipeline","source":"Ashurst","summary":"Key Australian contract law lessons from recent cases - Ashurst","headline":"Key Australian contract law lessons from recent cases","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4wFBVV95cUxOR3Rwc2xRaG1NRW5nSmVOeHQwTDJjYXFjYjhlZzB1UVNYM1h2VTY2ZG9TSjZIamEyUk5waWJ2RFkwNGRmdDJ5YVctZ3Q5VUZsOExObERCRVl5TEJmeV9obGFMYjFlZ05aSTcwd0hYc0pxd3V2bHl2T3dvNlhlMkYwQjdsdVBCZjJDRFBBQ2ZTRnFhS19CY3lCZ203dW5hMVhGQ0JWN2NqRGtSQ1pYYnBlaUxrREN0NUtTRHozVWs5WW9DcURDdzdxaS1zUFlBNWVidGYwLURQZU10Y2xHNFNYcEtBbw?oc=5","date":"2026-01-19","type":"pipeline","source":"Capital Brief","summary":"Mayne Pharma weighs sale of US operations to unlock shareholder value - Capital Brief","headline":"Mayne Pharma weighs sale of US operations to unlock shareholder value","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizAFBVV95cUxNM2lYX0ZCdFVIZjJNTjdscXFQT3ZwTElMY21pMjIyRGtOa2lKWkdDTjFHVHFLbU1BRmRzejhmYVZGNDZZekhWRnptSWdFdk8ySF9IUGhPZW11SC1oM2tPb3pZOUVZejZ0UjViekRiVVVwaFhraFdJbmNIZEgxQnRGTW5QbmxaWnVCbTBXMllCWE96ZUFHUm5VSU5mQ09aTURXRTRsUWpZblZmNG5iVy1jRzR5MFBidXlZbVhhbU16WmtaMUxlaXNpdDFBdlA?oc=5","date":"2025-12-22","type":"earnings","source":"AFR","summary":"Mayne Pharma under earnings pressure after failed takeover deal - AFR","headline":"Mayne Pharma under earnings pressure after failed takeover deal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxNMGxIdF9QRTNMNTNpa2paWm94M2VmT3J6NVRSS2ItYUpheDlQcUNaeUsta1h0V3I5OTcyZmtYYmdxLVJoaHVQaTRadTlwLXQzWk91enVrS2I2eGxwX1JaR0p1VmhVcUNFWFQ5Rm8tTEJVNGFxbDFwWW1Pdk92UlQ5TEl2VVdSaERzbUt2QmVoSG94eDZ6aTZTY2JwYjQ?oc=5","date":"2025-12-22","type":"pipeline","source":"The Motley Fool Australia","summary":"Mayne Pharma signals short-term pain as it resets for growth - The Motley Fool Australia","headline":"Mayne Pharma signals short-term pain as it resets for growth","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxPSlFzSlhUYmxubXNfX3FrRHpPZDV5WUxpY2lVaTQ2NURjRjVMUUtZdm5DVkVYNDhZaTI0TDNkNE1sdnNTLVN2T0Y4MnRnazBSTGNhSXBxdTVpZzJEVXh5dHU4SW91TGlNV1V6cTF1Z1Eyc04xYi1uWEJGSEJHX0NkeFVOTS1kNlZmckk0c1pWTkZxRlJrb1c4?oc=5","date":"2025-12-16","type":"pipeline","source":"grafa.com","summary":"Mayne Pharma unveils $18M expanded Salisbury facility - grafa.com","headline":"Mayne Pharma unveils $18M expanded Salisbury facility","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiygFBVV95cUxPLUwwQVJCZUltUHdmTjUwZmxhTFVIaFF1UHVUWVVZY000VVdfaUlJQmVuU3NsRDB5cUs5RE8xUmFzTFF1c1ZvcDFWV3g5UFh5cFE5bWdiUDJ5UEp3VEZhdHVpbzVRNXhlTkd3RVFUWURDM1Q2UF8xVjlmX2hXV09TR3U3VGZjdFhZOXVtZks2dmpSRjJhMWJSRUpTYU9nUnJlSTh5UkFHOEJacnpOQnJXbk9YMFVfNHVkRjU4UkdDZjFSb2plWmVhTU5R?oc=5","date":"2025-11-24","type":"deal","source":"Proactive financial news","summary":"Mayne Pharma continues slide after Treasurer blocks deal - Proactive financial news","headline":"Mayne Pharma continues slide after Treasurer blocks deal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihAFBVV95cUxQSmF1aWhlblBIc3dRQ3dzRFBxQWtjbjZQTElYbXY0NmJLR2NDTXF1UE0wOHV0Q0h6TnQ3SE5yMUtWMUtxVjR6ejYyLTlUUHNjaC12NEt1MDZMWUtRWmFZSmhoTmtKYWJKS202NWRELXRLeXdQM3pUM3pHb29rZXg0TmFac3k?oc=5","date":"2025-11-20","type":"pipeline","source":"jws.com.au","summary":"The sleeper issue in the Mayne Pharma scheme - jws.com.au","headline":"The sleeper issue in the Mayne Pharma scheme","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi7gFBVV95cUxNMkFUbGluNzUwSlVpN2gzMTU1ZF9RMC1abjBGc3lGMllCM2FLNHFWTHlUb0hrQnNINTBROU1NaTlVQVk4VzRPem9kbmJwdzJwZTNpMUhtNjBmaDRjenFTalczTFdvWTNjMTZHOXFXMVpobFZmNU1qWmtfYzlzd1ZGUXd6TWNhdnB5dGdmTmlhR2kzMktVQUVtem12U1ZzdHFUR3FrREQ2dGJybVUxRTMxODZ4NlFJSkFqRjA2TUdRVXA3X0lkNEhIa2F1UXMtV3hWNnVXbVNXdURiVHBHT0RqX2djQnhqd01jTEtrSGp30gHzAUFVX3lxTE8xWWNiWkJfblBMNXNrcVM0cFFMMHJvZWdLbm5ydVdETEpHMnBUWGU3WmxuRldiR0VNMTF6M19VRDIxeGwwNDFJaWxhUmJaUGRWRFJOS29ROHZuNVZoS3ZRalBXTWdWSHJOMVRPazFXSkdGVmFaaUswUkZZZjFqenRwcjAteWxLTjRXV1dVekllNUx3NXlOS1VXalhaZlZiZEdmaDRaNGxZUEtZZmVHekZHY1oxWnZOZVZUVHNnQ3Mta2xsMFJ2Yk9SWUFmYmtYTXpjRUhmaW16NmxrV09zdWpsSkZ3b0c4a2l1cTQwaXMweFA0TQ?oc=5","date":"2025-11-03","type":"pipeline","source":"The Australian","summary":"Treasurer’s intervention likely to trigger Mayne Pharma break-up - The Australian","headline":"Treasurer’s intervention likely to trigger Mayne Pharma break-up","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAJBVV95cUxPdm5vbGswTDUzdmQ4STdYM2NqeG5UOHN6NkhVUEx1UFJqWGluMDdPSW9fZXhTUzZkdndqSWhYWHBhUkJadFI3NTl4QTNNbXQzYzlmVVJWSVJHaXlxOEZQS29yMm5wU21UY01iTW9RbFZVX1NpVnhhSG9oQnVEWnpVWmF5aURfUFBSU09kT1V2VTFjYnlDZ1ZNNWxObjlMTldKMG5pRDFlbWNJaU9tVDRwM1BmcFZIb1o4WEZGNXlRTHhWcGVnZE9vSGlzY2taMU1acDlvU3R5WFAtdDdKbWg4ODZVWF9SOWJ1TWM1QnJ5R3ZsSUkxbVgzbnBZV0xtTGU2TWwwbnF2RzFwNzI2VGtZbFlpTzI?oc=5","date":"2025-02-20","type":"pipeline","source":"Business Wire","summary":"Cosette Pharmaceuticals Announces Acquisition of Mayne Pharma, Transforming Company into a Leader in Women’s Health and Dermatology - Business Wire","headline":"Cosette Pharmaceuticals Announces Acquisition of Mayne Pharma, Transforming Company into a Leader in Women’s Health and ","sentiment":"neutral"}],"patents":[],"drugCount":6,"phaseCounts":{"marketed":5,"phase_3":1},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}